SMS Biological Division was launched in 1985 in exclusive association with Institut Merieux / Sanofi Pasteur – France.

SMS was the pioneering company to introduce a broad range of Human Vaccines and Sera from Institut Merieux that later merged with Sanofi Pasteur.

SMS, over the next two decades, became the leading provider of critical and life-saving vaccines to all public sector hospitals around the country.

In 2006, the entire SA business moved to Sanofi Aventis – Pakistan owing to the change of their global strategy and policy. SMS helped Sanofi Pakistan in smooth transfer of knowledge and product licenses for their entire biological business.

SMS has since moved forward and is now marketing and distributing the contemporary pharmaceutical and biological products including Vaccines, Recombinant Proteins and Blood Derivatives from world renowned companies from EU, USA, India, China, Russia and Korea approved by WHO, US-FDA, EMEA, CE and are ISO Certified.